Haug Partners Successfully Defends Takeda's Vyvanse® Patents At Trial Against Generic Challenge | Haug Partners LLP
On December 27, 2022, Haug Partners LLP and Gibbons PC obtained a key victory as to all counts for its client, plaintiffs Takeda Pharmaceutical Co. Ltd. and Takeda Pharmaceuticals...
Source: jdsupra.com